$PRVCF struck a deal with private firm Asterion Cannabis, Inc. to develop medical CBD products. In the companies’ sights via the joint venture are tablets, transdermal patches and other jointly evaluated products aimed at treating chronic pain, inflammation, epilepsy, anxiety disorders and others.